Effect of Treatment with Gibberellin, Gibberellin Biosynthesis Inhibitor, and Auxin on Steviol Glycoside Content in Stevia rebaudiana Bertoni
Effect of Treatment with Gibberellin, Gibberellin Biosynthesis Inhibitor, and Auxin on Steviol Glycoside Content in Stevia rebaudiana Bertoni
复制标题
赤霉素、赤霉素生物合成抑制剂和生长素处理对甜叶菊甜菊糖苷含量的影响
DOI:
10.1007/s12355-017-0561-3
复制
发表时间:
2017
期刊:
影响因子:
1.9
通讯作者:
Ohdoi Katsuaki
中科院分区:
文献类型:
--
作者:
Yoneda Yuki;Shimizu Hiroshi;Nakashima Hiroshi;Miyasaka Juro;Ohdoi Katsuaki
Steviol glycosides (SGs) are natural compounds present inStevia rebaudiana(Bertoni) Bertoni, which are approximately 200–400 times sweeter than sucrose. A biosynthetic pathway of SGs shares a biosynthetic pathway of gibberellin (GA) through a formation ofent-kaurenoic acid. Previous studies have demonstrated that SG-related genes are upregulated by exogenous GA treatment. However, the transcription level ofUGT85C2,which is involved in a glycosylation step to steviol from steviolmonoside and suggests a rate-limiting step in the SGs biosynthesis, remains controversial in GA treatments. To have a detailed understanding of the relationship between SGs and GAs, a concentration gradient of exogenous GA3, GA inhibitor daminozide (DAM), and naphthaleneacetic acid (NAA) was used for treatment by the leaf infiltration method. Results showed that transcription level ofUGT85C2and the total number of stevioside and rebaudioside-A induced by GA3, DAM, or NAA treatment were significantly upregulated compared to an untreated group. These results suggest that the GA biosynthetic pathway affects the number of SGs and that hormonal crosstalk occurs between GA and auxin, which changes the number of SGs inS.rebaudiana. Controlling the GA biosynthesis could be considered to modulate the yield of SGs.